Like shares, leaps, and September 20th 25C's at .65 a contract
RNA company with one of the largest pipelines in the industry, biotech sector likely to see a tailwind in markets with rates coming down over the next 12 months
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.